• Mashup Score: 2

    As COVID-19 vaccines are rolled out globally, the AstraZeneca vaccine (Vaxzevria) continues to be marred in controversy, from its slow and still awaited approval by the US Food and Drug Administration amid concerns about paucity of large-scale trial data from the USA, to safety alerts around the development of rare blood clotting events coupled with thrombocytopenia, particularly cerebral venous…

    Tweet Tweets with this article
    • Our Editorial discusses SARS-CoV-2 vaccination and rare blood clotting events #COVID19 #thrombosis #anticoag https://t.co/4QwPCeAnci https://t.co/Ymga0GYg9i

  • Mashup Score: 0

    A 51-year-old woman attended our emergency department with a 3-day history of dyspnoea, fatigue, and cough; 11 days earlier she had the ChAdOx1 nCoV-19 vaccination. On examination she was afebrile, her peripheral oxygen saturation was 98% (fraction of inspired O2 21%), blood pressure was 150/90 mm Hg, heart rate was 98 beats per min, and body-mass index was 31 kg/m2.

    Tweet Tweets with this article
    • Clinical picture @TheLancet: Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination #thrombosis #anticoag #COVID19 📰Read the paper https://t.co/EQqm6aCGc5 📽️Watch the video https://t.co/dtllgLU19P